Skip to content

Arvinas ARVN Research and development expenses

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$518.11M-4.6%
Enterprise value$439.41M-7.1%
P/S5.8×+4.5×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0.0×
Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept arvn:AccruedResearchAndDevelopmentExpenseCurrent.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's research and development expenses.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arvinas's research and development expenses?
Arvinas (ARVN) reported research and development expenses of $17.4M in Q1 2026.
How has Arvinas's research and development expenses changed year-over-year?
Arvinas's research and development expenses decreased by 37.9% year-over-year, from $28M to $17.4M.
What is the long-term trend for Arvinas's research and development expenses?
Over 4 years (2021 to 2025), Arvinas's research and development expenses has grown at a 17.6% compound annual growth rate (CAGR), from $9.5M to $18.2M.